Comparison in Pulmonary Compliance Between Curosurf and Survanta in Preterm Infants With Respiratory Distress Syndrome

Withdrawn before enrolling · Not applicable

Conditions studied: Respiratory Distress Syndrome

In brief

This is a null hypothesis study. The investigators hypothesize that there will be no difference in changes in dynamic compliance when measured at 15, 30, 45 and 60 minute intervals after administration of either surfactant and there will be no differences in the number of doses needed between the two surfactants in premature infants admitted to our NICU.

Key facts

Study ID

NCT01537354

Run by

University of Michigan

People needed

0

Starts

2012-06-01

Last updated by the study team

2014-01-08

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Preterm infants between 28 and 31 6/7 weeks' gestational age
• Inborn to UM NICU
• < 12 hours of age
• Respiratory Distress Syndrome
• radiographic evidence
• need for endotracheal intubation
• Oxygen requirement > 30% FiO2
• Decision to give surfactant by the treatment team

You may not qualify if…

• Major congenital anomaly
• Sepsis syndrome in extremis

Where it is running

• University of Michigan C & W Mott Children's Hospital — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.